Last Updated: Wednesday, November 27, 2013, 15:46
In a filing to the BSE, the company said it has received a warning letter from USFDA for its manufacturing units located at L1, Chikalthana, Aurangabad and B15, Waluj, Aurangabad.
Last Updated: Sunday, June 23, 2013, 13:27
The two firms will synergise across each segment of pharmaceutical value chain starting from R&D, sourcing, manufacturing, distribution, sales and marketing, he added.
Last Updated: Wednesday, June 05, 2013, 19:01
Generic drugs distributed in South Africa by Indian pharmaceutical giant Ranbaxy are "safe" and "efficacious", the country's regulator body said Wednesday, days after the beleaguered drug maker paid a fine of USD 500 million in the US for selling adulterated drugs there.
Last Updated: Friday, April 19, 2013, 16:49
German drug major Bayer AG Friday said it "disagrees" with a US court ruling that allowed Indian rival Lupin to sell generic version of its oral contraceptive (OC) tablet 'Yaz' in the American market and is "evaluating" options.
Last Updated: Friday, April 12, 2013, 18:53
Drug major Lupin Friday said it has received US health regulator's approval for generic version of Teva Branded Pharm's Seasonique Tablets, used to prevent pregnancy, in the American market.
Last Updated: Thursday, January 31, 2013, 14:07
India is hard selling its cost effective generic drugs to Iran and competing against the expensive medicines from Europe.
Last Updated: Sunday, December 09, 2012, 11:37
The Government plans to bring a new legislation for price control and monitoring of drugs, replacing the existing regulatory framework, to meet the requirements of the new pharmaceutical pricing policy.
Last Updated: Friday, November 23, 2012, 17:38
Drug major Ranbaxy Friday said it is recalling its generic version of cholesterol-lowering drug Lipitor from the US market leading to temporary disruption in the supply.
Last Updated: Sunday, September 09, 2012, 11:06
With an aim to increase India's pharma exports, the Department of Commerce has formed a consultative group comprising government officials and industry representatives.
Last Updated: Wednesday, August 08, 2012, 16:22
Alembic Pharaceuticals Ltd on Wednesday said it has entered into a drug development and licensing agreement with US-based Accu-Break Pharmaceuticals under which it plans to launch over five generic drugs in the next two to three years.
Last Updated: Monday, August 06, 2012, 13:44
Both the companies said they would immediately commence distribution of the product in the US market.
Last Updated: Sunday, June 24, 2012, 15:45
India`s ambitious plan to provide free medicines to all will be launched from October, says a government report.
more videos >>